These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22687488)

  • 1. Understanding the influence of alendronate on the morphology and phase transformation of apatitic precursor nanocrystals.
    Zhang G; Huang R; Li Z; Yang X; Chen X; Xia W; Sun X; Yang G; Gao C; Gou Z
    J Inorg Biochem; 2012 Aug; 113():1-8. PubMed ID: 22687488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalization of biomimetic calcium phosphate bone cements with alendronate.
    Panzavolta S; Torricelli P; Bracci B; Fini M; Bigi A
    J Inorg Biochem; 2010 Oct; 104(10):1099-106. PubMed ID: 20638728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells.
    Panzavolta S; Torricelli P; Bracci B; Fini M; Bigi A
    J Inorg Biochem; 2009 Jan; 103(1):101-6. PubMed ID: 18977031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical analysis of calcium phosphate precipitation in simulated body fluid.
    Lu X; Leng Y
    Biomaterials; 2005 Apr; 26(10):1097-108. PubMed ID: 15451629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).
    Schott H; Goltz D; Schott TC; Jauch C; Schwendener RA
    Bioorg Med Chem; 2011 Jun; 19(11):3520-6. PubMed ID: 21536448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorption and conformational change of myoglobin on biomimetic hydroxyapatite nanocrystals functionalized with alendronate.
    Iafisco M; Palazzo B; Falini G; Foggia MD; Bonora S; Nicolis S; Casella L; Roveri N
    Langmuir; 2008 May; 24(9):4924-30. PubMed ID: 18373380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on in vitro biocompatibility of synthetic octacalcium phosphate and calcium phosphate ceramics used clinically.
    Morimoto S; Anada T; Honda Y; Suzuki O
    Biomed Mater; 2012 Aug; 7(4):045020. PubMed ID: 22740587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of nucleation in transformation of octacalcium phosphate to hydroxyapatite.
    Ito N; Kamitakahara M; Yoshimura M; Ioku K
    Mater Sci Eng C Mater Biol Appl; 2014 Jul; 40():121-6. PubMed ID: 24857473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(γ-benzyl-L-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting.
    de Miguel L; Noiray M; Surpateanu G; Iorga BI; Ponchel G
    Int J Pharm; 2014 Jan; 460(1-2):73-82. PubMed ID: 24211357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of collagen/hydroxyapatite/alendronate hybrid hydrogels as potential scaffolds for bone regeneration.
    Ma X; He Z; Han F; Zhong Z; Chen L; Li B
    Colloids Surf B Biointerfaces; 2016 Jul; 143():81-87. PubMed ID: 26998869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of alendronate doped calcium phosphates on bone cells activity.
    Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A
    Bone; 2012 Nov; 51(5):944-52. PubMed ID: 22878156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of brushite and octacalcium phosphate in apatite formation.
    Johnsson MS; Nancollas GH
    Crit Rev Oral Biol Med; 1992; 3(1-2):61-82. PubMed ID: 1730071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells.
    Boanini E; Torricelli P; Gazzano M; Giardino R; Bigi A
    Biomaterials; 2008 Mar; 29(7):790-6. PubMed ID: 18022226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiresorptive and anti-angiogenetic octacalcium phosphate functionalized with bisphosphonates: An in vitro tri-culture study.
    Forte L; Torricelli P; Boanini E; Gazzano M; Fini M; Bigi A
    Acta Biomater; 2017 May; 54():419-428. PubMed ID: 28238916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Alendronate release from a calcium phosphate bone cement: An in vitro osteoblast-osteoclast co-culture study.
    Dolci LS; Panzavolta S; Torricelli P; Albertini B; Sicuro L; Fini M; Bigi A; Passerini N
    Int J Pharm; 2019 Jan; 554():245-255. PubMed ID: 30423416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study on the morphological and release properties of hydroxyapatite-alendronate composite materials.
    Capra P; Dorati R; Colonna C; Bruni G; Pavanetto F; Genta I; Conti B
    J Microencapsul; 2011; 28(5):395-405. PubMed ID: 21736524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel osteoporotic drug delivery system in vitro: alendronate-loaded calcium phosphate cement.
    Jindong Z; Hai T; Junchao G; Bo W; Li B; Qiang WB
    Orthopedics; 2010 Aug; 33(8):. PubMed ID: 20704104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the systemic administration of alendronate on bone formation in a porous hydroxyapatite/collagen composite and resorption by osteoclasts in a bone defect model in rabbits.
    Sugata Y; Sotome S; Yuasa M; Hirano M; Shinomiya K; Okawa A
    J Bone Joint Surg Br; 2011 Apr; 93(4):510-6. PubMed ID: 21464492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic fabrication of fibrin/apatite composite material.
    Yoh R; Matsumoto T; Sasaki J; Sohmura T
    J Biomed Mater Res A; 2008 Oct; 87(1):222-8. PubMed ID: 18085654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.
    Cruz L; Assumpção E; Andrade SF; Conrado DJ; Kulkamp IC; Guterres SS; Pohlmann AR
    Eur J Pharm Sci; 2010 Aug; 40(5):441-7. PubMed ID: 20471479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.